Recent Patents on Anti-Infective Drug Discovery
Volume 15, 3 Issues, 2020
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Recent Patents on Anti-Infective Drug Discovery, Volume 13 - Number 2
Biography Open Access
Editorial Open Access
Nanomedicine Advances in Topical Infective and Non-Infective Skin Diseases Therapy
, 13(2): 104Mahfoozur Rahman, Sohail Akhter and Sarwar Beg
DOI: 10.2174/1574891X1302181106123659
Review Article
Nanotechnological Carriers for Treatment of Acne
, 13(2): 105 - 126Shivani Verma, Puneet Utreja and Lalit Kumar*
DOI: 10.2174/1574891X13666180918114349
Nanotechnological Carriers for Treatment of Acne
Review Article
Current State of Nanomedicines in the Treatment of Topical Infectious Disorders
, 13(2): 127 - 150Kanika Thakur, Gajanand Sharma, Bhupinder Singh, Sanjay Chhibber and Om P. Katare*
DOI: 10.2174/1574891X13666180529103804
Current State of Nanomedicines in the Treatment of Topical Infectious Disorders
Review Article
Nano-Based Therapy for Treatment of Skin Cancer
, 13(2): 151 - 163Sadaf J. Gilani, Mohammed A. Jahangir, Chandrakala, Md. Rizwanullah, Mohamad Taleuzzaman, Mohammad S. Shahab, Kashif Shakeel, Mohd. Aqil and Syed S. Imam*
DOI: 10.2174/1574891X13666180911095440
Nano-Based Therapy for Treatment of Skin Cancer
General Review Article
Screening and Potential of the Incidence of Resistance Transfer Among the Multidrug and Heavy Metal Resistant Gram-Negative Isolates from Hospital Effluents of Northern India
, 13(2): 164 - 179Manzar Alam and Mohd. Imran*
DOI: 10.2174/1574891X13666180702111330
Screening and Potential of the Incidence of Resistance Transfer Among the Multidrug and Heavy Metal Resistant Gram-Negative Isolates from Hospital Effluents of Northern India
General Research Article
Evaluation of Fosfomycin Activity Against Extended Spectrum Beta Lactamase (ESBL) Producing Enterobacteriaceae Isolated from Three Centers of Tehran, Iran
, 13(2): 180 - 186Roya Ghanavati, Elnaz Ohadi, Hossein Kazemian, Fateme Yazdani, Alireza Torki, Behrooz S. Kalani and Gholamreza Irajian*
DOI: 10.2174/1574891X13666180517075803
Evaluation of Fosfomycin Activity Against Extended Spectrum Beta Lactamase (ESBL) Producing Enterobacteriaceae Isolated from Three Centers of Tehran, Iran
Patent Selections Open Access
Editor-in-Chief
Tianhong Dai
Massachusetts General Hospital
Harvard Medical School
Boston, MA
(USA)
Biography
Massachusetts General Hospital
Harvard Medical School
Boston, MA
Biography
Biography of Tianhong Dai
Tianhong Dai is an assistant professor with the Harvard Medical School. He is considered a world leader in antimicrobial blue light therapy for infections, and a world expert in animal models of wound infections using bioluminescent microbes. He is the author and co-author of more than 80 peer-reviewed publications. Dr. Dai’s research has been supported by the NIH (R01 and R21), DoD and other funding sources.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Recent Patents on Anti-Infective Drug Discovery was launched in 2006. Dr. Tianhong Dai serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.10
New eBook
 |
Frontiers in Clinical Drug Research-Anti InfectivesYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net